New Delhi [India], December 15 (ANI): Informing that the Drugs Controller General of India has granted clearance for the clinical trials of one more candidate vaccine from India, NITI Aayog Member (Health) Dr VK Paul on Tuesday said six vaccines are currently undergoing clinical trials in
Tel Aviv [Israel], December 15 (ANI/Sputnik): The Israel Institute for Biological Research (IIBR) has successfully completed phase one of the domestic coronavirus vaccine trials and plans to start phase two of the clinical trials in the coming days, the Israeli Defense Ministry said on Monda
Moscow [Russia], December 14 (ANI): The efficacy of the Sputnik V COVID-19 vaccine has been confirmed to be 91.4 per cent, based on data analysis of the final control point of clinical trials, announced the Gamaleya National Center of Epidemiology and Microbiology and the Russian Direct I
Geneva [Switzerland], December 12 (ANI/Sputnik): The World Health Organization (WHO) is encouraged by the growth in the number of vaccines against COVID-19 that have performed well in clinical trials, although the organization remains concerned by the limited number of doses currently ava
New Delhi [India], December 11 (ANI): In a major development in the fight against COVID-19, India's first indigenous mRNA vaccine candidate has received approval from Indian Drug regulators to initiate Phase I/II human clinical trial.
Tokyo [Japan], December 8 (ANI/Sputnik): Japan's AnGes biopharmaceutical company said on Tuesday that it had started phase 2 clinical trials of its DNA vaccine against the coronavirus.
New Delhi [India], December 2 (ANI): After phase 2/3 clinical trials for Sputnik V commenced in India on Tuesday, Russian Ambassador Nikolay Kudashev said comprehensive cooperation in countering the spread of coronavirus is a priority area of the Russia-India bilateral and multilateral strat
New Delhi [India], December 1 (ANI): Phase 2/3 clinical trials for Sputnik V, the first registered Covid-19 vaccine from Russia commenced in India on Tuesday.
New Delhi [India], November 23 (ANI): With an efficacy of around 90 per cent positive results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil the vaccine has proved to be highly effective in preventing COVID-19, said AstraZeneca on Monday.
Madrid [Spain], November 18 (ANI/Sputnik): The Spanish Agency of Medicines and Medical Devices (AEMPS) authorized phase 3 clinical trials of the COVID-19 vaccine developed by Janssen, a subsidiary of the Johnson & Johnson company, the Spanish Health Ministry said on Wednesday.
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.
Massachusetts [US], November 16 (ANI): US biotech company Moderna on Monday announced a new potential Covid-19 vaccine, which has been shown to be 94.5 per cent effective at protecting people from coronavirus, according to interim results from late-stage clinical trials.